NON-SMALL CELL SQUAMOUS LUNG CANCER
Clinical trials for NON-SMALL CELL SQUAMOUS LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL SQUAMOUS LUNG CANCER trials appear
Sign up with your email to follow new studies for NON-SMALL CELL SQUAMOUS LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smart immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new type of CAR T cell therapy for adults with advanced solid tumors, including colorectal, pancreatic, lung, ovarian, and mesothelioma cancers. The therapy uses a patient's own immune cells, modified to target cancer cells while sparing healthy ones. The goal …
Matched conditions: NON-SMALL CELL SQUAMOUS LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New cancer drug NXP900 enters first human tests
Disease control Recruiting nowThis early-phase study tests a new drug called NXP900 in about 140 adults with advanced solid tumors (like lung, kidney, or mesothelioma) that have not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the drug can shrink tumors…
Matched conditions: NON-SMALL CELL SQUAMOUS LUNG CANCER
Phase: PHASE1 • Sponsor: Nuvectis Pharma, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC